News

Dose-escalation studies aspire to fill gaps in cancer treatment options
2/26/2024
Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.
Celebrating Women in Science
2/9/2024
In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.
Virtual education: Food and common cancer myths
3/14/2024
Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.
Studies address need for more treatment options in endometrial cancer and AML
1/24/2024
New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy
Promising results of amivantamab studies appear in high-profile journals
3/13/2024
New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.
A remarkable year of engagement and advancements at Providence Cancer Institute
1/10/2024
Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.
Immunotherapies for GI and lung cancers evaluated in new studies
11/20/2023
A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.
Genomic testing can improve outcomes for people with advanced cancer, study shows
11/3/2023
Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.
Providence researchers contribute to 21 studies at SITC2023
11/20/2023
SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.
Watch a free virtual talk on lung cancer prevention and treatment
Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.
New studies address unmet needs in treating triple-negative breast cancer
10/12/2023
Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.
Dr. Urba receives award for his contributions to science and community
10/4/2023
Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.